company background image
MVF

Monash IVF GroupASX:MVF Stock Report

Market Cap

AU$362.4m

7D

0.5%

1Y

66.1%

Updated

22 Oct, 2021

Data

Company Financials +
MVF fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance4/6
Financial Health4/6
Dividends3/6

MVF Overview

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

Price History & Performance

Summary of all time highs, changes and price drops for Monash IVF Group
Historical stock prices
Current Share PriceAU$0.95
52 Week HighAU$0.56
52 Week LowAU$1.03
Beta1.8
1 Month Change-1.04%
3 Month Change9.14%
1 Year Change66.09%
3 Year Change4.37%
5 Year Change-54.31%
Change since IPO-49.87%

Recent News & Updates

Jun 06
Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Monash IVF Group Limited ( ASX:MVF ), might not be a large cap stock, but it saw a significant share price rise of over...

May 25
Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

May 13
Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

Today we will run through one way of estimating the intrinsic value of Monash IVF Group Limited ( ASX:MVF ) by taking...

Shareholder Returns

MVFAU HealthcareAU Market
7D0.5%1.1%0.7%
1Y66.1%13.1%21.4%

Return vs Industry: MVF exceeded the Australian Healthcare industry which returned 13.1% over the past year.

Return vs Market: MVF exceeded the Australian Market which returned 21.4% over the past year.

Price Volatility

Is MVF's price volatile compared to industry and market?
MVF volatility
MVF Beta1.8
Industry Beta0.60
Market Beta1

Stable Share Price: MVF is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: MVF's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014669Michael Knaaphttps://www.monashivfgroup.com.au

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility research and treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services.

Monash IVF Group Fundamentals Summary

How do Monash IVF Group's earnings and revenue compare to its market cap?
MVF fundamental statistics
Market CapAU$362.36m
Earnings (TTM)AU$25.15m
Revenue (TTM)AU$183.61m

14.8x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MVF income statement (TTM)
RevenueAU$183.61m
Cost of RevenueAU$117.21m
Gross ProfitAU$66.40m
ExpensesAU$41.25m
EarningsAU$25.15m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.065
Gross Margin36.16%
Net Profit Margin13.70%
Debt/Equity Ratio0.6%

How did MVF perform over the long term?

See historical performance and comparison

Dividends

4.4%

Current Dividend Yield

65%

Payout Ratio

Valuation

Is Monash IVF Group undervalued compared to its fair value and its price relative to the market?

39.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MVF (A$0.96) is trading below our estimate of fair value (A$1.57)

Significantly Below Fair Value: MVF is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MVF is good value based on its PE Ratio (14.8x) compared to the Australian Healthcare industry average (24.7x).

PE vs Market: MVF is good value based on its PE Ratio (14.8x) compared to the Australian market (19.8x).


Price to Earnings Growth Ratio

PEG Ratio: MVF is poor value based on its PEG Ratio (7x)


Price to Book Ratio

PB vs Industry: MVF is good value based on its PB Ratio (1.4x) compared to the AU Healthcare industry average (2.2x).


Future Growth

How is Monash IVF Group forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

2.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MVF's forecast earnings growth (2.1% per year) is above the savings rate (1.9%).

Earnings vs Market: MVF's earnings (2.1% per year) are forecast to grow slower than the Australian market (11.5% per year).

High Growth Earnings: MVF's earnings are forecast to grow, but not significantly.

Revenue vs Market: MVF's revenue (3.7% per year) is forecast to grow slower than the Australian market (5.3% per year).

High Growth Revenue: MVF's revenue (3.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MVF's Return on Equity is forecast to be low in 3 years time (9%).


Past Performance

How has Monash IVF Group performed over the past 5 years?

-12.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MVF has high quality earnings.

Growing Profit Margin: MVF's current net profit margins (13.7%) are higher than last year (8.1%).


Past Earnings Growth Analysis

Earnings Trend: MVF's earnings have declined by 12.3% per year over the past 5 years.

Accelerating Growth: MVF's earnings growth over the past year (114.5%) exceeds its 5-year average (-12.3% per year).

Earnings vs Industry: MVF earnings growth over the past year (114.5%) exceeded the Healthcare industry 61.3%.


Return on Equity

High ROE: MVF's Return on Equity (9.5%) is considered low.


Financial Health

How is Monash IVF Group's financial position?


Financial Position Analysis

Short Term Liabilities: MVF's short term assets (A$22.5M) do not cover its short term liabilities (A$41.1M).

Long Term Liabilities: MVF's short term assets (A$22.5M) do not cover its long term liabilities (A$41.2M).


Debt to Equity History and Analysis

Debt Level: MVF's debt to equity ratio (0.6%) is considered satisfactory.

Reducing Debt: MVF's debt to equity ratio has reduced from 61.3% to 0.6% over the past 5 years.

Debt Coverage: MVF's debt is well covered by operating cash flow (2704.4%).

Interest Coverage: MVF's interest payments on its debt are well covered by EBIT (13.9x coverage).


Balance Sheet


Dividend

What is Monash IVF Group current dividend yield, its reliability and sustainability?

4.40%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: MVF's dividend (4.4%) is higher than the bottom 25% of dividend payers in the Australian market (2.27%).

High Dividend: MVF's dividend (4.4%) is low compared to the top 25% of dividend payers in the Australian market (5.31%).


Stability and Growth of Payments

Stable Dividend: MVF has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: MVF has only been paying a dividend for 7 years, and since then payments have fallen.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (65.1%), MVF's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: MVF's dividends in 3 years are forecast to be covered by earnings (69.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.8yrs

Average management tenure


CEO

Michael Knaap

3yrs

Tenure

AU$908,159

Compensation

Mr. Michael D. Knaap serves as Chief Executive Officer, Managing Director and Director of Monash IVF Group Limited since April 15, 2019. Mr. Knaap served as an Interim Chief Executive Officer of Monash IVF...


CEO Compensation Analysis

Compensation vs Market: Michael's total compensation ($USD680.12K) is about average for companies of similar size in the Australian market ($USD559.78K).

Compensation vs Earnings: Michael's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: MVF's management team is considered experienced (2.8 years average tenure).


Board Members

Experienced Board: MVF's board of directors are considered experienced (7.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Monash IVF Group Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Monash IVF Group Limited
  • Ticker: MVF
  • Exchange: ASX
  • Founded: 2014
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: AU$362.360m
  • Shares outstanding: 389.63m
  • Website: https://www.monashivfgroup.com.au

Number of Employees


Location

  • Monash IVF Group Limited
  • Pelaco Building 1
  • Level 1
  • Richmond
  • Victoria
  • 3121
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/22 07:05
End of Day Share Price2021/10/22 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.